Navigation Links
ORF Genetics Opens Revolutionary 'Green Factory' in Iceland
Date:5/13/2008

Human growth factors produced in barley grain, using renewable, geothermal energy

REYKJAVIK, Iceland, May 13 /PRNewswire-USNewswire/ -- ORF Genetics (http://www.orfgenetics.com), an Icelandic biotechnology company, announced today the opening of new and revolutionary 22,000 ft^2 (2043m^2) cultivation facilities in Grindavik, Iceland. Utilizing its unique Orfeus(TM) protein production system in barley, ORF Genetics produces and markets biorisk-free ISOkine(TM) human growth factors for use in medical research, drug discovery and cosmetics.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080513/DC22192 )

The state-of-the-art Green Factory uses geothermal energy for safe, indoor cultivation of genetically engineered barley. It is set in the middle of a lava field, close to Icelands best-known tourist attraction, the Blue Lagoon. The barley is cultivated in a soil-less hydroponic system on specially designed conveyor belts, allowing for the production of up to 90 different proteins at a time. The Orfeus(TM) system and new facilities allow ORF the flexibility to easily scale their production according to the unique requirements of different customers and markets. Currently ORF has more than 100 different growth factors in its pipeline and 10 ISOkine(TM) growth factors already on the market.

Bjorn L. Orvar, CEO of ORF Genetics, said at the opening of the greenhouse: "Our research and development efforts in recent years are now bearing fruit, and we see great opportunities for rapid growth, specifically in the field of drug discovery and cosmetics."

Minister of Industry Ossur Skarphedinsson said as he harvested the first barley in the Green Factory: "ORF's ideas have sprouted from the dynamic Icelandic public research environment, and the company's leaders, with unflagging entrepreneurial optimism, have overcome all difficulties, making ORF a unique high-tech company in the world. The new 'Green Factory' leverages the company's deserved green image, as production is based on green and renewable energy from Iceland's volcanic depths."

ORF will be exhibiting their products in the US at the upcoming Supplier's Day Show hosted by the New York Society for Cosmetic Chemists in May.

ORF Genetics

Headquartered in Reykjavik, Iceland, ORF Genetics Ltd. is a privately owned biotech company that is committed to economically viable green technology for the production of growth factors and other hard-to-produce recombinant proteins. Utilizing its unique Orfeus(TM) plant-based expression system, the company is currently producing biorisk-free, high purity ISOkine(TM) products to serve the needs of the medical research, cell culture media, diagnostics and cosmetic markets. ORF was recently awarded the prestigious 2008 Icelandic Innovation Award by the Icelandic Centre for Research and the Icelandic Trade Council.


'/>"/>
SOURCE ORF Genetics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
2. Response Genetics Reports Second Quarter 2007 Financial Results
3. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
4. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
5. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
6. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
7. Interleukin Genetics Announces Management and Board Appointments
8. Response Genetics Announces Presentations/Webcasts at Upcoming Investor Conferences
9. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
10. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
11. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... The global chronic kidney disease ... by Transparency Market Research (TMR). The top four players, ... Inc., accounted for a share of only 41.4% in ... market are focusing aggressively on mergers, acquisitions, and strategic ... to lead to market consolidation in the next few ...
(Date:3/22/2017)... 2017   Boston Biomedical , an industry leader ... target cancer stemness pathways, today announced its Board of ... Chief Executive Officer, effective April 24, 2017. ... , M.D., FACP, who has led Boston Biomedical since ... leadership, Boston Biomedical has grown from a "garage startup" ...
(Date:3/22/2017)... Freeport, Grand Bahama (PRWEB) , ... March 21, 2017 , ... ... a free educational seminar as part of their live events series, “Stem Cell Therapy: ... adult stem cell facility under the 2013 Stem Cell Research and Therapy Act, ...
(Date:3/22/2017)... , ... March 21, 2017 , ... ... , more than tripling its goal and raising over $30,000 in the first ... that grows nutritious veggies & herbs fast, easy, and affordably, anywhere. , “Simply ...
Breaking Biology Technology:
(Date:3/7/2017)... CITY , March 7, 2017   HireVue ... help top global companies identify the best talent, faster, ... as Chief Sales Officer (CSO) and Diana Kucer ... appointments round out a seasoned executive team poised to drive ... beyond, building on a year of record bookings in ...
(Date:3/2/2017)... , March 2, 2017 Summary This ... Perrigo and its partnering interests and activities since 2010. ... Read the ... and Alliance since 2010 report provides an in-depth insight into ... sciences companies. On demand company reports are prepared ...
(Date:3/2/2017)... March 2, 2017 Who risk to be ... Download the full report: https://www.reportbuyer.com/product/4313699/ WILL ... SENSOR FIELD? Fingerprint sensors using capacitive technology represent ... sensor vendor Idex forecasts an increase of 360% of ... and of the fingerprint sensor market between 2014 and ...
Breaking Biology News(10 mins):